Supriya Lifescience Limited

NSE:SUPRIYA.NS

609.25 (INR) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

2023202220212020201920182017
Revenue 5,703.74,609.385,193.743,853.653,116.452,778.42,129.14
Cost of Revenue 3,051.91,808.122,298.8641,511.671,627.471,735.21,778.17
Gross Profit 2,651.82,801.262,894.8762,341.981,488.981,043.2350.97
Gross Profit Ratio 0.4650.6080.5570.6080.4780.3750.165
Reseach & Development Expenses 10.8512.3716.626.6110.577.787.06
General & Administrative Expenses 0192.26137.32105.17104.869.5162.96
Selling & Marketing Expenses 0238.67223.75231.2135.38113.7267.27
SG&A 1,080.15430.93361.07336.37240.18183.22166.47
Other Expenses 106.3594.890.1139.6983.5548.14-10.53
Operating Expenses 1,080.151,630.42873.31735.79564.45432.22184.06
Operating Income 1,571.651,171.682,043.391,663.851,008.07610.98166.91
Operating Income Ratio 0.2760.2540.3930.4320.3230.220.078
Total Other Income Expenses Net 85.2563.1929.069.24-45.8-39.94-22.27
Income Before Tax 1,656.91,234.872,072.451,673.93962.27571.04144.64
Income Before Tax Ratio 0.290.2680.3990.4340.3090.2060.068
Income Tax Expense 465.76336.3554.35435.65228.24176.7957.36
Net Income 1,191.14898.571,518.11,235.93734.03394.2487.28
Net Income Ratio 0.2090.1950.2920.3210.2360.1420.041
EPS 14.811.1618.8616.8910.0315.431.19
EPS Diluted 14.811.1618.8616.8910.0315.431.19
EBITDA 1,729.761,383.862,205.431,781.261,089.12702.54220.23
EBITDA Ratio 0.3030.30.4250.4620.3490.2530.103